Progressive adoption of cryoablative therapy for breast fibroadenoma in community practice

Michael J. Edwards, Ralph Broadwater, Lorraine Tafra, Daleela Jarowenki, Charles Mabry, Peter Beitsch, Pat Whitworth, Robert C. Martin, Lori Oetting

Research output: Contribution to journalArticlepeer-review

32 Scopus citations


Cryoablation is a recent technological advance and has been used for the percutaneous treatment of breast fibroadenomas. Herein, we provide a retrospective summary of the early experience from a nationwide group. We organized a national registry to document the community practice and adoption of an office-based system of cryoablation for breast fibroadenoma. Data were abstracted during the first 6 weeks after the procedure to assess acute outcome and potential complications. At 6-and 12-month follow-up intervals, additional data were collected regarding fibroadenoma resolution, cosmesis, and patient satisfaction. Fifty-three sites ablated 310 fibroadenomas. Early follow-up data on 256 lesions showed that the procedure was well tolerated with infrequent minor complications immediately after the procedure. At 6 and 12 months postprocedure, the remaining fibroadenoma volume progressively involuted.At both intervals, cosmesis was excellent, and patient satisfaction was rated high. An early community experience with office-based cryoablation of breast fibroadenomas is encouraging and comparable to the initial experience of high-volume tertiary centers. More follow-up is necessary to determine long-term results and residual mammographic changes.

Original languageEnglish (US)
Pages (from-to)221-224
Number of pages4
JournalAmerican journal of surgery
Issue number3
StatePublished - Sep 2004


  • Breast
  • Cryoablation
  • Fibroadenoma

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Progressive adoption of cryoablative therapy for breast fibroadenoma in community practice'. Together they form a unique fingerprint.

Cite this